While some studies found that the expression levels of caspase-3 correlated with poor prognosis for the disease outcome [179], others reported that the levels of caspase-3 in cancer samples were extremely low or even non-detectable [180], suggesting that further activity studies are needed to fully understand the role of caspases and to evaluate them as prospective disease biomarkers. Here, CASP3 is linked to cancer.